Skip to content

The Effects of Device-Guided Breathing Exercises on Blood Pressure, in Patients with Hypertension. A Randomized, Single-Blind, Controlled Trial

The Effects of Device-Guided Breathing Exercises on Blood Pressure, in Patients with Hypertension. A Randomized, Single-Blind, Controlled Trial - Breathing Exercises and Blood Pressure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32130
Enrollment
30
Registered
2008-01-29
Start date
2008-02-04
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensie High Blood Pressure Hypertension

Interventions

Resperate© is a device that helps to slow down breathing. This device can measure the breathing patterns through a breathing sensor mounted on the upper abdomen or chest. Furthermore, music-like sou

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients are required to meet the following criteria: over 18 years old, known hypertension with a systolic BP (SBP) between 130-170 mm Hg at the previous visit to the internal outpatient department and at the last visit to the internist (which is the same day as baseline measurement) and treated with one or more anti-hypertensive drugs, which have not been changed for the preceding three months. At baseline the SBP should be between 140-160 mm Hg, measured by the investigator.

Exclusion criteria

Exclusion criteria: Patients with known diabetes, heart failure (NYHA III-IV) and/or patients with pulmonary disease (for example asthma, chronic obstructive pulmonary disease and pulmonary fibrosis) will be excluded by the discretion of the treating internist. Patients with insufficient knowledge of the Dutch language to understand the requirements of the study will be excluded too.

Design outcomes

Primary

MeasureTime frame
Changes in office systolic blood pressure in the intervention group compared to changes in the controlgroup.

Secondary

MeasureTime frame
Changes in office diastolic blood pressure in the intervention group compared to changes in the controlgroup. Changes in systolic and diastolic blood pressure as measured by the patient at home in the intervention group compared to changes in the controlgroup. Changes in Quality of Life in the intervention group compared to changes in the controlgroup.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)